DYNAMIC WEALTH RESEARCH
  • Stocks
  • Hard Assets
  • Cannabis
  • Tech
  • Biotech Stocks
  • About Us
  • Contact
  • News
  • Special Report
  •  
  •  
  •  

News

 News Home

Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application for the Treatment of Behavioral Addictions

Awakn Life Sciences announces filing a patent application for the treatment of behavioral addictions with ketamine-assisted psychotherapy.

05/26/2022 PSW Editor

PharmaTher To Develop and Commercialize Novel Wearable Ketamine Delivery Device in Collaboration with CCBIO

Pharmather announces a new development agreement with CCBIO to create a proprietary wearable ketamine delivery solution for mental health.

05/25/2022 PSW Editor

Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation

Optimi Health announces the completion of its first crop of psilocybin mushrooms at the company's Princeton, B.C. cultivation facility.

05/25/2022 PSW Editor

Small Pharma Shares Business Update Ahead of Annual Financial Results

Small Pharma issues a corporate update, reporting R&D and IP progress, with ~CAD$40 million in cash as of February 28, 2022.

05/25/2022 PSW Editor

Why Is The Psychedelic Drug Industry Suddenly In Favor With Global Power Players?

The psychedelic drug industry has suddenly attracted the attention of the most influential "power players" on the planet. It's great news for the industry, but...

05/24/2022 Jeff Nielson

MindMed Appoints Schond L. Greenway as Chief Financial Officer

MindMed announces the appointment of Schond L. Greenway as its new CFO, bringing a wealth of experience in banking and corporate finance.

05/23/2022 PSW Editor

COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting

Compass Pathways announces the release of the largest randomized, controlled, double-blind study ever completed on psilocybin-assisted therapy.

05/23/2022 PSW Editor

GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

GH Research reports its Q1 2022 results. Net loss of $5.8 million. Cash position of $270.8 million as of March 31, 2022.

05/20/2022 PSW Editor

Seelos Therapeutics Receives a Notice of Allowance in the U.S. for an Additional Patent for SLS-007

Seelos Therapeutics announces receiving its Notice of Allowance from the USPTO for SLS-007 as a method of treatment.

05/19/2022 PSW Editor

Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions

Awakn Life Sciences announce promising results from the first study of ketamine-assisted therapy for behavioral addictions, and will be initiating a larger follow-up study.

05/19/2022 PSW Editor

Mydecine Announces Size of Previously Announced Overnight Marketed Public Offering of Units

Mydecine Innovations Group announces the issuance of 3,478,260 units at a unit price of CAD$1.15, for gross proceeds of up to CAD$4 million.

05/19/2022 PSW Editor

Novamind Launches Group Psychedelic Treatment for Frontline Workers

Novamind announces the full-scale launch of Frontline KAP, group-based ketamine-assisted therapy for frontline healthcare workers suffering from burnout/stress/trauma, at select clinic locations.

05/19/2022 PSW Editor
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 243
  • Next

Exclusives

Responsive image
Jerome Powell: The Boy Who Cried “Rate Hike”

Today Jerome Powell and the Federal Reserve shocked markets by forecasting two rate hikes for 2023. The real "shock" would be if he actually delivered on those words.


Gold Confiscation and Cryptocurrencies

Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise

The MYTH That Real Estate Is A Great Investment

Why Gold Is The Ultimate Shield Against Inflation

Crypto Crashes, Real Estate Bubbles: Gold Is The Only Safe Haven

SHARE DYNAMIC WEALTH RESEARCH

Our Mission

Learn More


  • About
  • Contact

Contact Us


info@dynamicwealthresearch.org
2010 West Avenue K #623
Lancaster, CA 93536

Subscribe to Newsletter

Stay informed on new causes and upcoming organization updates. Don't miss things!

By providing your e-mail, you are consenting to receive press releases and other information concerning Psychedelic Stock Watch and its affiliates and partners. You may withdraw your consent at any time.

UNSUBSCRIBE
© 2016 - 2022 DYNAMIC WEALTH RESEARCH, Privacy Policy, Disclaimer
powered by structure cms™